Supreme Court Declines to Review Drug Reps Classification Issue
Despite the Circuit split created by this month’s decision from the Ninth Circuit, holding that pharmaceutical sales representatives are outside sales employees within the meaning of the FLSA, the Supreme Court has declined to take up Novartis’ appeal of the adverse ruling it received on this issue from the Second Circuit. The Supreme Court’s ruling was contained in its Order List for February 28, and does not provide any insight into the Court’s thinking.
